Initially focussing on variants in the same ±2.5 kB region as before, we found circulating CETP increased CHD risk, consistent with the findings of a recent large-scale clinical trial where CETP inhibition reduces CHD risk (Fig. 5). The gene discussed is CETP; the disease is coronary artery disorder.